Sector
PharmaceuticalsOpen
₹100.15Prev. Close
₹100.04Turnover(Lac.)
₹15.42Day's High
₹101.97Day's Low
₹99.0552 Week's High
₹157.9852 Week's Low
₹78.06Book Value
₹71.29Face Value
₹10Mkt Cap (₹ Cr.)
159.11P/E
20.52EPS
4.9Divi. Yield
1.1914 Aug 2024
12:00 AM
AGM
Announcement Date: 14 Aug, 2024
15 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.8 | 15.69 | 15.76 | 15.76 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 89.78 | 80.34 | 71.56 | 63.56 |
Net Worth | 105.58 | 96.03 | 87.32 | 79.32 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 249.3 | 170.67 | 223.07 | 209.84 |
yoy growth (%) | 46.07 | -23.49 | 6.3 | -7.13 |
Raw materials | -150.58 | -84.21 | -116.93 | -100.62 |
As % of sales | 60.39 | 49.34 | 52.41 | 47.94 |
Employee costs | -39.61 | -48.76 | -48.45 | -49.61 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 9.79 | -9.07 | 4.41 | 8.45 |
Depreciation | -7.25 | -7.02 | -6.11 | -6.72 |
Tax paid | -0.69 | 0.17 | 2.34 | -2.51 |
Working capital | 21.59 | -16.12 | 17.18 | 19.67 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 46.07 | -23.49 | 6.3 | -7.13 |
Op profit growth | 289.87 | -66.75 | -10.21 | 12.42 |
EBIT growth | 551.42 | -80.28 | -3.55 | 2.99 |
Net profit growth | -202.18 | -231.68 | 13.83 | 11.75 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 303.08 | 339.22 | 304.22 | 281.21 | 250.53 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 303.08 | 339.22 | 304.22 | 281.21 | 250.53 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.2 | 2.85 | 0.98 | 5.15 | 1.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Shailesh Siroya
Executive Director
Himesh Virupakshaya
Independent Director
H S Venkatesh
Independent Director
Nicola Neeladri
Independent Director
Jatish Sheth
Whole-time Director
Kotian Chittananda Damodar
Company Sec. & Compli. Officer
Abdul Basith
21 & 22 Bommasandra Indl Area,
Hosur Road,
Karnataka - 560092
Tel: -
Website: http://www.balpharma.com
Email: [email protected]
C-101 1st Floor,
247 Park Vikhroli W, Lal Bahadur Marg,
Mumbai - 400 083
Tel: -
Website: www.tsrdarashaw.com
Email: [email protected]
Summary
Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 87. In Mar.90, BPL took over a pharmaceutical products manufacturing unit located in...
Read More
Reports by Bal Pharma Ltd
What is the Bal Pharma Ltd share price today?
What is the Market Cap of Bal Pharma Ltd?
What is the PE and PB ratio of Bal Pharma Ltd?
What is the 52 Week High and Low of Bal Pharma Ltd?
What is the CAGR of Bal Pharma Ltd?
What is the shareholding pattern of Bal Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.